共 20 条
- [1] Reciprocal control of miR-197 and IL-6/STAT3 pathway reveals miR-197 as potential therapeutic target for hepatocellular carcinoma [J]. ONCOIMMUNOLOGY, 2015, 4 (10):
- [2] IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma [J]. FRONTIERS IN ONCOLOGY, 2021, 11
- [4] miR-224 Regulates the Aggressiveness of Hepatoma Cells Through the IL-6/STAT3/SMAD4 Pathway [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2021, 32 (06): : 532 - 542